Stockreport

Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis"), a late-stage clinical drug platform company pioneering transformative thera [Read more]